- Category
- Micro (2023-24)
- Udyam number
- UDYAM-RJ-02-0057077

Relevix Pharmaceutical LLP
About Relevix Pharmaceutical LLP
Data last updated:
Relevix Pharmaceutical LLP is a limited liability partnership (LLP) based in Tijara, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 April 2023.
The LLP is registered with the Registrar of Companies (ROC), Jaipur, under LLPIN ACA-8421.
The LLP has a total obligation of contribution of ₹10 Lakh. It is led by designated partners Himanshu Gupta and Umesh Aggarwal.
Its latest statement of accounts is for the year ended 31 March 2024. The registered office is at Tijara, Rajasthan.
Relevix Pharmaceutical LLP is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-02-0057077).
Company details
Recognitions & Rankings of Relevix Pharmaceutical
Contact details
Relevix Pharmaceutical LLP's registered office is in Tijara, Rajasthan.
- Registered AddressPlot No. – G – 163 RIICO Industrial Area, Kaharani Bhiwadi Distt, Tijara, Rajasthan, India – 301019
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Relevix Pharmaceutical LLP
FY 2024 filings availableFinancial Statement Summary
| Statement of Account and Solvency | FY 2023-24 |
|---|---|
| Income and Expenditure | |
| Turnover | |
| Other Income | |
| Total Income | |
| Purchases and Direct Costs | |
| Personnel Expenses | |
| Administrative Expenses | |
| Interest | |
| Depreciation | |
| Total Expenses | |
| Profit Before Tax | |
| Tax | |
| Profit After Tax | |
| Profit Transferred to Partners | |
| Assets and Liabilities | |
| Partners' Contribution | |
| Reserves and Surplus | |
| Secured Loans | |
| Unsecured Loans | |
| Trade Payables | |
| Other Liabilities and Provisions | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Loans and Advances | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Statement of Account and Solvency | FY 2023-24 |
|---|---|
| Profitability | |
| Net Profit Margin | |
| Return on Partners' Funds | |
| Return on Assets | |
| Liquidity and Debt | |
| Current Ratio | |
| Debt to Partners' Funds | |
| Interest Coverage | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Turnover Growth | |
| Profit Growth | |
To see the full financial statements and ratios of Relevix Pharmaceutical LLP, buy the company report.
Designated partners of Relevix Pharmaceutical LLP
Relevix Pharmaceutical has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Himanshu Gupta Also directs: Novamark Remedies Private Limited | Designated Partner | 28 Apr 2023 | 3 Years 6 Months | Current |
| Umesh Aggarwal | Designated Partner | 28 Apr 2023 | 3 Years 6 Months | Current |
Legal cases
No court or tribunal cases involving Relevix Pharmaceutical LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Relevix Pharmaceutical LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Relevix Pharmaceutical LLP; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Relevix Pharmaceutical LLP has 2 designated partner changes on record since 2023: 2 appointments. The latest: Himanshu Gupta was appointed as Designated Partner on 28 Apr 2023.
Frequently asked questions
Relevix Pharmaceutical is an active limited liability partnership based in Tijara, Rajasthan, India. The LLP works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 April 2023 (3+ years old) and is registered under LLPIN ACA-8421.
Relevix Pharmaceutical has 2 current designated partners:
- Himanshu Gupta - Designated Partner
- Umesh Aggarwal - Designated Partner
The latest financial statements of Relevix Pharmaceutical on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2024 are in the company report.
The LLPIN (Limited Liability Partnership Identification Number) of Relevix Pharmaceutical is ACA-8421. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Relevix Pharmaceutical was incorporated on 28 April 2023, making it 3+ years old. It is registered with the Registrar of Companies, Jaipur.
Himanshu Gupta was appointed as Designated Partner on 28 Apr 2023. Umesh Aggarwal was appointed as Designated Partner on 28 Apr 2023.
Yes, Relevix Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-02-0057077).
The registered office of Relevix Pharmaceutical is at Plot No. – G – 163 RIICO Industrial Area, Kaharani Bhiwadi Distt, Tijara, Rajasthan, India – 301019.
Relevix Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Relevix Pharmaceutical can be reached at its registered office: Plot No. – G – 163 RIICO Industrial Area, Kaharani Bhiwadi Distt, Tijara, Rajasthan, India – 301019.

